25 April 2024
Alkema M et al. BMC Med 22: 170, 2024
Alkema M, Smit MJ, Marin-Mogollon C, Totté K, Teelen K, van Gemert GJ, van de Vegte-Bolmer M, Mordmüller BG, Reimer JM, Lövgren Bengtsson KL, Sauerwein RW, Bousema T, Plieskatt J, Theisen M, Jore MM and McCall MB. A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial. [PubMed]